Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Networks02:26

Protein Networks

4.0K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Cancer Survival Analysis01:21

Cancer Survival Analysis

410
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
410
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K
Overview of Cell Death01:30

Overview of Cell Death

7.5K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiscale Analysis of Reinforced Concrete Frames with Embedded Metamaterials Under Progressive Collapse.

Materials (Basel, Switzerland)·2026
Same author

CRISPR-Cas9 Genome and Double-Knockout Screening to Identify Novel Therapeutic Targets for Chemoresistance in Triple-Negative Breast Cancer.

Cancers·2025
Same author

A multi-layer encoder prediction model for individual sample specific gene combination effect (MLEC-iGeneCombo).

PLoS computational biology·2025
Same author

A compendium of synthetic lethal gene pairs defined by extensive combinatorial pan-cancer CRISPR screening.

Genome biology·2025
Same author

GenRCA: a user-friendly rare codon analysis tool for comprehensive evaluation of codon usage preferences based on coding sequences in genomes.

BMC bioinformatics·2024
Same author

Synthetic lethal connectivity and graph transformer improve synthetic lethality prediction.

Briefings in bioinformatics·2024

Related Experiment Video

Updated: Aug 12, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K

Multi-view graph convolutional network for cancer cell-specific synthetic lethality prediction.

Kunjie Fan1, Shan Tang2, Birkan Gökbağ1

  • 1Department of Biomedical Informatics, The Ohio State University, Columbus, OH, United States.

Frontiers in Genetics
|January 26, 2023
PubMed
Summary

This study introduces MVGCN-iSL, a new computational model for identifying cancer-specific synthetic lethal (SL) gene pairs. It improves targeted cancer therapy research by predicting SL interactions more accurately using multi-omics data.

Keywords:
deep learninggraph neural networksmulti-omicssynthetic lethalitysystems biology

More Related Videos

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

513
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.7K

Related Experiment Videos

Last Updated: Aug 12, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

513
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.7K

Area of Science:

  • Computational biology
  • Genomics
  • Bioinformatics

Background:

  • Synthetic lethal (SL) interactions are crucial for developing targeted cancer therapies.
  • Wet-lab screening for SL gene pairs is time-consuming and expensive.
  • Existing computational methods, including graph neural networks (GNNs), often lack cancer cell specificity and fail to fully leverage diverse biological features.

Purpose of the Study:

  • To develop a novel computational method for predicting cancer cell-specific SL gene pairs.
  • To improve the accuracy and efficiency of identifying potential therapeutic targets for cancer.

Main Methods:

  • Proposed MVGCN-iSL, a multi-view graph convolutional network (GCN) model.
  • Integrated five biological graph features and multi-omics data.
  • Utilized max pooling for integrating GCN representations and a deep neural network (DNN) for prediction of cancer cell-specific SL interactions (iSL).

Main Results:

  • MVGCN-iSL successfully integrated multiple graph features and multi-omics data.
  • The model achieved state-of-the-art performance in predicting SL gene pairs.
  • Demonstrated strong generalization ability to novel genes.

Conclusions:

  • MVGCN-iSL offers a powerful computational approach for discovering cancer cell-specific SL interactions.
  • The model enhances the potential for developing targeted cancer therapeutics.
  • Highlights the importance of integrating diverse biological features for improved predictive accuracy.